510(k) device
iFuse Bedrock Granite Implant System
SI-BONE, Inc. · Sacroiliac Joint Fixation (OUR, Class II) · First FDA decision May 26, 2022, newest Oct 9, 2025Low back pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
Breakthrough-designated
Device trials
1
Naming "iFuse Bedrock Granite"
MAUDE reports
0
Brand "iFuse Bedrock Granite", since 2015
PubMed studies
1
Mentioning "iFuse Bedrock Granite"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing iFuse Bedrock Granite Implant System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K253094 · Decided Oct 9, 2025 · 16 days after receipt
Device type: Sacroiliac Joint Fixation (OUR) · Orthopedic Surgery
K233508 · Decided Jan 26, 2024 · 87 days after receipt
Device type: Sacroiliac Joint Fixation (OUR) · Orthopedic Surgery
- iFuse Bedrock Granite® Implant SystemBreakthrough510(k)
K222774 · Decided Dec 22, 2022 · 99 days after receipt
Device type: Sacroiliac Joint Fixation (OUR) · Orthopedic Surgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sacroiliac Joint Nerve BlocksProposed local determinationProposedDL40419First Coast Service Options, Inc.Updated Oct 30, 2026
- Sacroiliac Joint Nerve BlocksProposed local determinationProposedDL40417Novitas Solutions, Inc.Updated Oct 30, 2026
- Sacroiliac Joint Injections and ProceduresLocal determinationIn effectL39455Wellpoint FederalUpdated Jul 14, 2026
- Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) JointLocal determinationIn effectL36406Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Sacroiliac Joint Injections and ProceduresLocal determinationIn effectL39383CGS Administrators, LLCUpdated Mar 27, 2026
- Sacroiliac Joint Injections and ProceduresLocal determinationIn effectL39462Noridian Healthcare Solutions, LLCUpdated Feb 23, 2026
- Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)Local determinationIn effectL39810Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "iFuse Bedrock Granite", any status and sponsor, newest update first.
- Pelvic Fixation and Fusion During Multilevel Spinal SurgeryActive, not recruiting
SI-BONE, Inc.Public (SIBN)
NCT05640908 · 200 participants (planned) · Start Jun 5, 2023 · Primary completion Nov 2027
Device: iFuse Bedrock Granite Implant System · For: Spinal Fusion; Deformity of Spine
Sites: Mobile, Alabama; Aurora, Colorado; Royal Oak, Michigan · 9 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "iFuse Bedrock Granite", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OUR
1,084 reports: 19 malfunction, 1,056 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "iFuse Bedrock Granite"[tiab]. The summary above synthesizes these.
- Removal of infected bone in-growth pelvic fixation implants and microcomputed tomography analysis of osseous integration: illustrative case.
Spence BS, Godlewski MW, Haselhuhn JJ, et al. · J Neurosurg Case Lessons · 2024
Other devices of this type
Also filed under product code OUR.
- iFuse Implant System®SI-BONE, Inc. · 510(k) 2019
- SImmetry Sacroiliac Joint Fusion SystemZyga Technology, Inc. · 510(k) 2015
- TiLink-P SI Joint Fusion SystemSurGenTec, LLC · 510(k) 2024
- FIREBIRD SI Fusion SystemOrthofix, Inc. · 510(k) 2021
- CATAMARAN SI Joint Fusion SystemTenon Medical · 510(k) 2026
- iFuse TORQ® Implant SystemSI-BONE, Inc. · 510(k) 2024
- ZESPIN SI Joint Fusion SystemAegis Spine, Inc. · 510(k) 2023
- Life Spine SIMPACT Sacroiliac Joint Fixation SystemLife Spine, Inc. · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.